Skip to main content
Equibles
PGNY logo

PGNY · Progyny, Inc.

Track PGNY — free

Use PGNY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.94 -0.67 (-2.52%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.99B
Shares
76.73M

PGNY metrics

90 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.94
Market cap
$1.99B

Price action

19 metrics
Price change (1W)
-0.2%
Price change (30D)
-7.7%
Price change (3M)
+0.3%
Price change (6M)
+41.7%
Price change (YTD)
+1.0%
Price change (1Y)
+10.1%
Trailing year
Price change (5Y)
-55.1%
52-week high
$32.36
52-week low
$16.30
Change from 52-week high
-19.8%
Change from 52-week low
+59.1%
Annualized volatility
55.2%
Beta
0.4
RSI (14D)
41.7
Price vs SMA 50
-10.3%
Price vs SMA 200
+7.5%
Avg volume (3M)
1.21M
Relative volume
0.9
Average dollar volume
$34.09M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
76.73M

Valuation

12 metrics
P / E (TTM)
28.2
Trailing earnings · reciprocal yield 3.5%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.9%
P / book
4.4
reciprocal yield 22.8%
FCF yield
9.0%
TTM · current market cap
Buyback yield
11.6%
P / FCF
11.2
reciprocal yield 9.0%
P / operating cash flow
9.9
reciprocal yield 10.1%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
38.3×
reciprocal yield 2.6%
P / E historical average (5Y)
57.3×
reciprocal yield 1.7%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
11.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
24.6%
Operating margin
8.6%
Trailing 12 months
Net margin
6.0%
Gross profit (TTM)
$322.09M
Operating profit (TTM)
$112.13M
Net income (TTM)
$78.63M
Trailing 12 months
Diluted EPS (TTM)
$0.92
FCF margin
13.6%
Effective tax rate
34.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$15.17
Gross profit per diluted share (TTM)
$3.73
Operating profit per diluted share (TTM)
$1.31
EBITDA per diluted share (TTM)
$1.38
Net income per diluted share (TTM)
$0.92
Operating cash flow per diluted share (TTM)
$2.32
Free cash flow per diluted share (TTM)
$2.06
Capital expenditures per diluted share (TTM)
$0.27
R&D per diluted share (TTM)
$0.14
Stock compensation per diluted share (TTM)
$1.23
Book value per share
$-18.45

Growth

11 metrics
Revenue growth YoY
+5.3%
Year over year
Net income growth YoY
+63.9%
Revenue (TTM)
$1.31B
Trailing 12 months
EPS growth YoY
+78.9%
Shares change YoY
-8.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+17.9%
Revenue CAGR (5Y)
+30.2%
EPS CAGR (3Y)
+29.4%
EPS CAGR (5Y)
+6.7%
FCF CAGR (3Y)
+35.5%
FCF CAGR (5Y)
+40.4%

Quality

14 metrics
Return on equity
17.3%
Return on assets
11.0%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
$117.87M
Free cash flow (TTM)
$178.38M
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$152.63M
Total assets
$715.84M
Total debt
$253,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$201.25M
Capital expenditures (TTM)
$22.86M
R&D (TTM)
$11.80M
SG&A (TTM)
—
Stock compensation (TTM)
$107.17M
R&D / revenue
0.9%
Stock compensation / revenue
8.2%

Ownership (13F)

3 metrics
13F filers
313
13F filer change QoQ
+18
Institutional ownership
102.8%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$70,910
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1551306 CUSIP 74340E103 13F (30d) 217 filings 213 filers Visit website Investor relations